While the underlying mechanisms of PLZF loss and related tumor progression as well as its role in PCa androgen independence have yet to be investigated, these data motivated us to examine the PLZF expression in prostate cancers with various grades (Gleason’s scores) as well as metastatic prostate cancers. Here, ZBTB16 is linked to prostate carcinoma.